Sobr Safe (SOBR) had the highest return between July 11, 2019 and December 31, 2019 by a US stock, returning 1,530.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Sobr Safe (SOBR) | 7/11/2019 - 12/31/2019 | 1,530.44% |
Castellum (CTM) | 7/11/2019 - 12/31/2019 | 791.67% |
Battalion Oil (BATL) | 7/11/2019 - 12/31/2019 | 572.5% |
Durect (DRRX) | 7/11/2019 - 12/31/2019 | 467.16% |
Kodiak Sciences (KOD) | 7/11/2019 - 12/31/2019 | 447.15% |
Pennant (PNTG) | 7/11/2019 - 12/31/2019 | 437.72% |
Relmada Therapeutics (RLMD) | 7/11/2019 - 12/31/2019 | 413.16% |
Neurogene (NGNE) | 7/11/2019 - 12/31/2019 | 411.2% |
N2OFF (NITO) | 7/11/2019 - 12/31/2019 | 380% |
Axsome Therapeutics (AXSM) | 7/11/2019 - 12/31/2019 | 299.38% |
Nisun International Enterprise Development (NISN) | 7/11/2019 - 12/31/2019 | 267.09% |
Cassava Sciences (SAVA) | 7/11/2019 - 12/31/2019 | 266.2% |
Applied Therapeutics (APLT) | 7/11/2019 - 12/31/2019 | 237.21% |
NextCure (NXTC) | 7/11/2019 - 12/31/2019 | 236.3% |
Immunitybio (IBRX) | 7/11/2019 - 12/31/2019 | 232.46% |
FuelCell Energy (FCEL) | 7/11/2019 - 12/31/2019 | 230.26% |
Avadel Pharmaceuticals (AVDL) | 7/11/2019 - 12/31/2019 | 218.57% |
Aurinia Pharmaceuticals (AUPH) | 7/11/2019 - 12/31/2019 | 213.14% |
GlucoTrack (GCTK) | 7/11/2019 - 12/31/2019 | 200% |
Aprea Therapeutics (APRE) | 7/11/2019 - 12/31/2019 | 196.83% |
Milestone Scientific (MLSS) | 7/11/2019 - 12/31/2019 | 195.74% |
Oncolytics Biotech (ONCY) | 7/11/2019 - 12/31/2019 | 193.83% |
InMode (INMD) | 7/11/2019 - 12/31/2019 | 190.37% |
Ardelyx (ARDX) | 7/11/2019 - 12/31/2019 | 185.36% |
Osisko Development (ODV) | 7/11/2019 - 12/31/2019 | 176% |
